News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
458,790 Results
Type
Article (25891)
Company Profile (97)
Press Release (432802)
Section
Business (159348)
Career Advice (2397)
Deals (25958)
Drug Delivery (79)
Drug Development (49005)
Employer Resources (142)
FDA (11193)
Job Trends (10322)
News (248916)
Policy (21995)
Tag
2024 BioCapital Digital (4)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (4)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (2)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Premier (1)
Academia (1862)
Academic (1)
Accelerated approval (6)
Adcomms (22)
Allergies (66)
Alliances (31431)
ALS (59)
Alzheimer's disease (937)
Antibody-drug conjugate (ADC) (73)
Approvals (11200)
Artificial intelligence (180)
Autoimmune disease (13)
Automation (12)
Bankruptcy (218)
Best Places to Work (8473)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (67)
Bladder cancer (47)
Brain cancer (21)
Breast cancer (173)
Cancer (1365)
Cardiovascular disease (109)
Career advice (1970)
Career pathing (30)
CAR-T (84)
Cell therapy (269)
Cervical cancer (12)
Clinical research (40344)
Collaboration (561)
Compensation (268)
Complete response letters (18)
COVID-19 (1955)
CRISPR (19)
C-suite (136)
Cystic fibrosis (63)
Data (1394)
Decentralized trials (2)
Denatured (5)
Depression (35)
Diabetes (173)
Diagnostics (4887)
Digital health (14)
Diversity (3)
Diversity, equity & inclusion (35)
Drug discovery (79)
Drug pricing (69)
Drug shortages (21)
Duchenne muscular dystrophy (59)
Earnings (90724)
Editorial (31)
Employer branding (18)
Employer resources (121)
Events (54712)
Executive appointments (406)
FDA (12087)
Featured Employer (33)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (450)
Gene editing (56)
Generative AI (19)
Gene therapy (216)
GLP-1 (477)
Government (3529)
Grass and pollen (3)
Guidances (46)
Healthcare (13673)
Huntington's disease (15)
IgA nephropathy (22)
Immunology and inflammation (80)
Indications (20)
Infectious disease (2057)
Inflammatory bowel disease (106)
Inflation Reduction Act (6)
Influenza (37)
Intellectual property (56)
Interviews (540)
IPO (13854)
IRA (35)
Job creations (2109)
Job search strategy (1582)
Kidney cancer (4)
Labor market (31)
Layoffs (358)
Leadership (18)
Legal (3887)
Liver cancer (50)
Lung cancer (201)
Lymphoma (85)
Machine learning (2)
Management (46)
Manufacturing (250)
MASH (39)
Medical device (9808)
Medtech (9810)
Mergers & acquisitions (12594)
Metabolic disorders (451)
Multiple sclerosis (51)
NASH (11)
Neurodegenerative disease (59)
Neuropsychiatric disorders (21)
Neuroscience (1303)
NextGen: Class of 2025 (4592)
Non-profit (3217)
Northern California (1755)
Now hiring (37)
Obesity (246)
Opinion (190)
Ovarian cancer (55)
Pain (60)
Pancreatic cancer (46)
Parkinson's disease (99)
Partnered (17)
Patents (129)
Patient recruitment (64)
Peanut (36)
People (30878)
Pharmaceutical (30)
Pharmacy benefit managers (10)
Phase I (11804)
Phase II (17691)
Phase III (14716)
Pipeline (931)
Podcasts (26)
Policy (92)
Postmarket research (1372)
Preclinical (4258)
Press Release (66)
Prostate cancer (65)
Psychedelics (25)
Radiopharmaceuticals (174)
Rare diseases (263)
Real estate (3761)
Recruiting (61)
Regulatory (16113)
Reports (32)
Research institute (1621)
Resumes & cover letters (394)
Rett syndrome (4)
RNA editing (2)
RSV (33)
Schizophrenia (54)
Series A (72)
Series B (46)
Service/supplier (8)
Sickle cell disease (35)
Southern California (1583)
Special edition (13)
Spinal muscular atrophy (89)
Sponsored (28)
Startups (1955)
State (2)
Stomach cancer (7)
Supply chain (49)
Tariffs (6)
The Weekly (21)
United States (15297)
Vaccines (511)
Venture capitalists (24)
Webinars (8)
Weight loss (167)
Women's health (16)
Worklife (17)
Date
Today (76)
Last 7 days (402)
Last 30 days (1798)
Last 365 days (24048)
2025 (6100)
2024 (25238)
2023 (28832)
2022 (37504)
2021 (39242)
2020 (39471)
2019 (33139)
2018 (25485)
2017 (23928)
2016 (22179)
2015 (25458)
2014 (19169)
2013 (15528)
2012 (16759)
2011 (17168)
2010 (15053)
Location
Africa (587)
Alabama (34)
Alaska (5)
Arizona (113)
Arkansas (9)
Asia (25200)
Australia (3856)
California (4044)
Canada (1359)
China (311)
Colorado (171)
Connecticut (192)
Delaware (85)
Europe (55861)
Florida (610)
Georgia (138)
Idaho (40)
Illinois (357)
India (25)
Indiana (214)
Iowa (4)
Japan (107)
Kansas (64)
Kentucky (18)
Louisiana (8)
Maine (52)
Maryland (656)
Massachusetts (2795)
Michigan (150)
Minnesota (249)
Mississippi (2)
Missouri (47)
Montana (17)
Nebraska (18)
Nevada (40)
New Hampshire (47)
New Jersey (1226)
New Mexico (20)
New York (1200)
North Carolina (738)
North Dakota (8)
Northern California (1755)
Ohio (124)
Oklahoma (9)
Oregon (18)
Pennsylvania (903)
Puerto Rico (8)
Rhode Island (19)
South America (857)
South Carolina (11)
Southern California (1583)
Tennessee (77)
Texas (562)
Utah (129)
Virginia (102)
Washington D.C. (38)
Washington State (360)
West Virginia (2)
Wisconsin (36)
458,790 Results for "qu biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Qu Biologics’ Immunomodulator Clears Senescence
February 11, 2025
·
5 min read
Press Releases
Qu Biologics’ Immunomodulator Improves Fatty Liver Disease
January 6, 2025
·
5 min read
Press Releases
Qu Biologics’ Site Specific Immunomodulator Enables CAR T-cell Cancer Efficacy in Solid Tumor
December 16, 2024
·
5 min read
Business
Qu Biologics and Foundation Medicine Collaborate to Impact the Care of Patients with Late-Stage Colorectal Cancer
Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators, a novel platform of immunotherapies designed to restore innate immune function, and Foundation Medicine, Inc. are pleased to announce a partnership aimed to impact the care of patients with late-stage colorectal cancer undergoing surgery.
June 6, 2024
·
4 min read
Business
Qu Biologics and TransBIOTech Awarded $450K Applied Research and Development Grant Funding
Qu Biologics Inc. is pleased to announce, in partnership with TransBIOTech (Quebec), being awarded an Applied Research and Development (ARD) grant via the College and Community Innovation (CCI) program administered through the Natural Sciences and Engineering.
March 11, 2024
·
5 min read
Qu Biologics Receives Accelerating Clinical Trial (ACT) Funding for PERIOP-06 Clinical Trial
Qu Biologics Inc. is pleased to announce that its Phase 2 clinical trial in late-stage colon cancer, PERIOP-06, was awarded CAD$400,000 in grant funding by the Accelerating Clinical Trial Canadian Consortium.
November 14, 2023
·
5 min read
Business
Dr. Matt Cahill Appointed Chief Operating Officer of Qu Biologics
Qu Biologics Inc. is pleased to announce the appointment of Matt Cahill MBA JD PhD, as Chief Operating Officer.
January 23, 2023
·
4 min read
Business
Qu Biologics and Karolinska Institute Initiate Important New Collaboration to Validate Molecular Mechanisms of Qu Biologics’ First-in-Class Immunotherapy Platform
Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is excited to announce a new collaboration with Associate Professor Jonas Fuxe and his research team at the Karolinska Institute (KI) in Stockholm, Sweden, to characterize the molecular targets of Qu’s SSI therapy at the tissue level that lead to resolution of disease.
December 14, 2022
·
5 min read
Press Releases
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
March 31, 2025
·
4 min read
Press Releases
ADMA Biologics Statement on Tariffs
April 8, 2025
·
4 min read
1 of 45,879
Next